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Tissue-engineered ureter using a decellularized matrix  
Partial ureterectomy is performed for patients with ureteral cancer or severe retroperitoneal 
fibrosis [1, 2]. When the length of the dissected ureter is long, especially proximally, ureteral 
replacement is required to avoid urinary diversion, such as nephrostomy or autorenal 
transplantation. However, previous trials using artificial materials have failed due to infection, 
inflammation, or calcification [3-7]. To improve the quality of life for patients undergoing 
nephrostomy, development of a novel graft material is needed. Decellularized matrices have 
been widely used as scaffolds for tissue engineering. Compared with biodegradable 
polymers, decellularized matrices possess physiological properties that are closer to those of 
normal tissue. These properties are beneficial for forming tubular structures, such as blood 
vessels, with similar pliancy to that of normal vessels [8]. Furthermore, decellularized 
matrices are highly biocompatible, which facilitates reepithelialization after transplantation [9]. 
This is of great benefit when a scaffold requires an epithelial lining. Decellularized matrices are 
also known to be minimally immunogenic, even in the case of xenografts, which is 
advantageous when a stable supply of scaffold material is required for clinical applications [10, 
11]. One of the most important factors for successful tissue-engineered ureters is thought to be 
a functional lining with uroepithelial cells (UECs), which are expected to maintain the luminal 
space, prevent calculus formation, and possibly resist stricture of the duct [3-6]. Fortunately, 
UECs from the bladder are readily available clinically, by endoscopy, without radical surgical 
procedures. Thus, the combination of an allogenic or xenogeneic decellularized ureter with 
autologous UECs might generate an ideal material for grafting. Decellularized matrices have 
been used to construct tissue-engineered urinary bladders and ureters in rat models [9-12]. 
However, replacement of the ureter in larger animals has not yet been successful [13]. We 
suggest that one of the major obstacles to application with the large animal models is 
providing a blood supply for the grafted epithelial cells, as the thickness of the scaffold in 
animals such as dogs is above the limit of diffusion for nutrients and oxygen from the 
surrounding tissue, causing the grafted cells to starve. Unlike tissue-engineered blood 
vessels, tissue-engineered ureters cannot access a blood supply until neovascularization is 
completed. In fact, our preliminary experiments have shown that epithelial cells seeded onto 
canine ureteral decellularized matrices (UDMs) gradually disappear over the 14-day period 
after transplantation. Several approaches have been developed in an attempt to improve the 
blood supply for the transplanted tissue, including the application of growth factors [14, 15]. 
Bone marrow-derived mononuclear cells (BM-MNCs) are known to contain endothelial 
progenitor cells and secrete several growth factors [16]. They have also been reported to 
accelerate neovascularization in ischemic diseases, such as Burger’s disease and ischemic 
heart disease, and might constitute a novel strategy for accelerating angiogenesis [17-19]. We 
were interested in whether BM-MNCs could facilitate neovascularization of a transplanted 
decellularized scaffold. The aim of the present study was to investigate the potential of the 
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decellularized ureter as a scaffold for constructing a tissue-engineered ureter and the role of 
BM-MNCs in enhancing angiogenesis in the UDM to enable the seeded UECs to survive. 
Below is a detailed explanation of the method.  
 
Generation of UDM 
To render the canine ureteral matrices decellular, they were excised from the beagles and 
treated with deoxycholic acid, as reported previously [9]. Briefly, the ureters were shaken in 10 
ml of 9.1 mM PBS containing 0.1% sodium azide for 12 hours in a humidified 5% CO2 
atmosphere at 37°C. Next, the samples were treated with 10 ml 0.1 M sodium chloride 
containing 0.2 mg/ml deoxyribonuclease for 12 hours, followed by 10 ml PBS containing 4% 
sodium deoxycholate and 0.1% sodium azide for 24 hours. The treated tissues were evaluated 
histologically to confirm their decellular status and assess damage to the extracellular matrices. 
The tissues were stored in PBS with 1% antibiotic-antimycotic solution at 4°C. 
 
Cell seeding on UDM surface 
Sections (2 cm) of the UDM were perfused with 5% fibronectin in PBS for 24 hours at 4°C in 
order to improve cell attachment. One end of the UDM was ligated, the inner space was 
filled with 1 × 106 cultured UECs, and the other end of the duct was ligated. The UDM was 
placed in a tube with culture medium and rotated for 8 hours. The ligatures were removed 
and the UDM with cells was incubated in a flask for a further 3 days before transplantation.  
 
Transplantation of UDMs with UECs: Experiment 1 
As a preliminary experiment, UDMs seeded with UECs (UDM-UECs) were transplanted to 
the omentum of nude rats in order to investigate the fate of the seeded cells. At the time of 
surgery, the animals were anesthetized with sodium pentobarbital (50 mg/kg body weight 
injected intraperitoneally). The samples were removed and evaluated histologically at 3 
days (n = 3) and 14 days (n = 3) after transplantation. 
 
BM-MNC seeding onto UDM-UEC: Experiment 2 
Bone marrow (10 ml) was aspirated from the iliac crests of dogs anesthetized with intravenous 
pentobarbital. BM-MNCs were isolated using a density-gradient method [19], according to the 
manufacturer’s protocol, and suspended at 1 × 106 cells/ml in DMEM. UDM-UECs were 
randomly divided into two groups. In group A (n = 3), the UDM-UECs were implanted into 
the subcutaneous space of nude mice without BM-MNCs, as controls. In group B (n = 3), 
BM-MNCs (3 × 105 cells in 300 µl) were seeded onto the outer surface of the UDM-UECs before 
transplantation. The grafts were removed and evaluated after 14 days. The effect of BM-MNCs 
on neovascularization in the grafts was assessed in two ways. First, the density of microvessels 
was measured by immunostaining with an antifactor VIII antibody by counting the number of 
microvessels in at least three fields (0.74 mm2) and calculating the mean number. Second, the 
distance from the inner surface of the UDM to the closest capillary was measured at 10 
randomly selected points in each graft, and the mean values were calculated. 
 
Combined effects of seeded BM-MNCs and the recipient site: Experiment 3 
To investigate the effects of the recipient site on neovascularization, UDM-UECs with 
BM-MNCs were transplanted into the omentum of nude rats and compared with those 
transplanted into the subcutaneous space of nude mice. The grafts were removed after 14 
days and processed for histological evaluation. 
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The cultured UECs began showing vacuolar degeneration 3 days after transplantation and 
gradually disappeared thereafter. To facilitate neovascularization in the implant, BM-MNCs 
were seeded around the UDM before transplantation. This facilitated the survival of the UECs, 
which formed three to five cellular layers after 14 days. The mean microvessel density was 
significantly increased in tissues seeded with BM-MNCs. However, cell-tracking experiments 
revealed that the increased number of capillaries in the experimental group was not due to the 
direct differentiation of transplanted endothelial progenitor cells. Our results demonstrate that 
the UDM is a useful scaffold for a tissue-engineered ureter, especially when seeded with 
BM-MNCs to enhance angiogenesis (Figs. 35, 36). 
 
 
Fig. 35. Bright-field photomicrographs showing H-E staining of tissue sections from UDM-UECs 
transplanted with BM-MNCs to nude mouse subcutaneous space (Experiment 2) (A) and to nude 
rat omentum (Experiment 3) (B). Histological section from UDM-UECs with BM-MNCs implanted 
into the omentum exhibited a thicker epithelial cell layer than these implanted into subcutaneous 
space. Samples were evaluated 14 day after transplantation. In both sections, capillaries were 
observed close to UECs (arrows) (From Matsunuma et al. 2006. Reprinted with permission).  
 
A B  
Fig. 36. Dark-field photomicrographs showing the results of cell-tracking experiments. 
BM-MNCs were labeled with the red fluorescent cell dye, PKH26, before being seeded onto 
implants, and sections of implants after 14 days were labeled for factor VIII in green using 
an FITC-labeled antibody. Note that only a few cells were double-labeled. A: Original 
magnification × 100; B: × 200 (From Matsunuma et al. 2006. Reprinted with permission).  
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This study of the initial establishment of grafts in vivo showed that UDMs were highly 
biocompatible with cultured UECs and should be a useful scaffold material for tissue-engineered 
ureters. Preseeding the grafts with BM-MNCs was a key factor in promoting the survival of the 
UECs by accelerating cell migration and neovascularization. 
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Tissue engineering, which aims at regenerating new tissues, as well as substituting lost organs by making use
of autogenic or allogenic cells in combination with biomaterials, is an emerging biomedical engineering field.
There are several driving forces that presently make tissue engineering very challenging and important: 1) the
limitations in biological functions of current artificial tissues and organs made from man-made materials alone,
2) the shortage of donor tissue and organs for organs transplantation, 3) recent remarkable advances in
regeneration mechanisms made by molecular biologists, as well as 4) achievements in modern biotechnology
for large-scale tissue culture and growth factor production. 
This book was edited by collecting all the achievement performed in the laboratory of oral and maxillofacial
surgery and it brings together the specific experiences of the scientific community in these experiences of our
scientific community in this field as well as the clinical experiences of the most renowned experts in the fields
from all over Nagoya University. The editors are especially proud of bringing together the leading biologists
and material scientists together with dentist, plastic surgeons, cardiovascular surgery and doctors of all
specialties from all department of the medical school of Nagoya University. Taken together, this unique
collection of world-wide expert achievement and experiences represents the current spectrum of possibilities in
tissue engineered substitution.
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